Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques

Vitamin K epoxide reductase (VKOR) is an enzyme that contributes to the synthesis of several clotting factors and its inhibition is a well-known mechanism of anticoagulant action. Though the VKOR inhibitor warfarin remains essential and popular today, its adverse effects still make it a high-risk me...

Full description

Saved in:
Bibliographic Details
Main Author: Mortel, Ser Loisse R.
Format: text
Language:English
Published: Animo Repository 2023
Subjects:
Online Access:https://animorepository.dlsu.edu.ph/etdm_chem/14
https://animorepository.dlsu.edu.ph/context/etdm_chem/article/1013/viewcontent/2023_Mortel_Identification_and_mechanistic_studies_of_potential_novel_vitamin_Full_text.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: De La Salle University
Language: English
id oai:animorepository.dlsu.edu.ph:etdm_chem-1013
record_format eprints
spelling oai:animorepository.dlsu.edu.ph:etdm_chem-10132023-09-07T07:55:00Z Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques Mortel, Ser Loisse R. Vitamin K epoxide reductase (VKOR) is an enzyme that contributes to the synthesis of several clotting factors and its inhibition is a well-known mechanism of anticoagulant action. Though the VKOR inhibitor warfarin remains essential and popular today, its adverse effects still make it a high-risk medication. This study intends to identify novel compounds with predicted VKOR inhibition and pharmacokinetic stability as well as explain the mechanistic basis of their action. A combination of pharmacophore modelling, druglikeness prediction, and molecular docking techniques was employed to find hits from existing compound libraries. Cell-based VKOR inhibition using the FIXgla-PC chimera reporter protein was then done to validate the in silico hits and determine the most potent hits. Fourteen hits showed suitable in vitro activity at the micromolar level, led by compound A116 (IC50 = 6.6 µM). The docked protein-ligand complexes of the in vitro hits were then subjected to molecular dynamics simulations to obtain atomic-level interaction information between the target and hits. High hydrogen bonding occupancies with Asn80, Cys135, and Tyr139 were noted for the top compounds, and ligand binding free energies were most significant at residues Phe55 to Phe63, Phe83, Leu120 to Leu128, and Cys135. Root-mean-square deviation (RMSD) measures suggest that VKOR inhibitors stabilize the luminal loop while root-mean-square fluctuation (RMSF) measures and network analyses add that inhibitors also reduce loop flexibility and residue communications. The combined in silico and in vitro data suggest that VKOR inhibitors must have a bicyclic nucleus that can elicit hydrophobic forces with luminal residues 55 to 63 and TM3 residues 120 and 128, as well as extensively hydrogen bond to Asn80 and Tyr139 or Cys135. Additionally, shorter side chains interact primarily with Phe83 while longer side chains interact with residues from Phe83 to Phe87. An extra side chain, like warfarin’s alkyl ketone, may not be essential. This proposed structure-activity relationship can serve as a useful guide for designing improved and novel vitamin K antagonists in the future. 2023-01-01T08:00:00Z text application/pdf https://animorepository.dlsu.edu.ph/etdm_chem/14 https://animorepository.dlsu.edu.ph/context/etdm_chem/article/1013/viewcontent/2023_Mortel_Identification_and_mechanistic_studies_of_potential_novel_vitamin_Full_text.pdf Chemistry Master's Theses English Animo Repository Vitamin K Enzymes Chemistry
institution De La Salle University
building De La Salle University Library
continent Asia
country Philippines
Philippines
content_provider De La Salle University Library
collection DLSU Institutional Repository
language English
topic Vitamin K
Enzymes
Chemistry
spellingShingle Vitamin K
Enzymes
Chemistry
Mortel, Ser Loisse R.
Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
description Vitamin K epoxide reductase (VKOR) is an enzyme that contributes to the synthesis of several clotting factors and its inhibition is a well-known mechanism of anticoagulant action. Though the VKOR inhibitor warfarin remains essential and popular today, its adverse effects still make it a high-risk medication. This study intends to identify novel compounds with predicted VKOR inhibition and pharmacokinetic stability as well as explain the mechanistic basis of their action. A combination of pharmacophore modelling, druglikeness prediction, and molecular docking techniques was employed to find hits from existing compound libraries. Cell-based VKOR inhibition using the FIXgla-PC chimera reporter protein was then done to validate the in silico hits and determine the most potent hits. Fourteen hits showed suitable in vitro activity at the micromolar level, led by compound A116 (IC50 = 6.6 µM). The docked protein-ligand complexes of the in vitro hits were then subjected to molecular dynamics simulations to obtain atomic-level interaction information between the target and hits. High hydrogen bonding occupancies with Asn80, Cys135, and Tyr139 were noted for the top compounds, and ligand binding free energies were most significant at residues Phe55 to Phe63, Phe83, Leu120 to Leu128, and Cys135. Root-mean-square deviation (RMSD) measures suggest that VKOR inhibitors stabilize the luminal loop while root-mean-square fluctuation (RMSF) measures and network analyses add that inhibitors also reduce loop flexibility and residue communications. The combined in silico and in vitro data suggest that VKOR inhibitors must have a bicyclic nucleus that can elicit hydrophobic forces with luminal residues 55 to 63 and TM3 residues 120 and 128, as well as extensively hydrogen bond to Asn80 and Tyr139 or Cys135. Additionally, shorter side chains interact primarily with Phe83 while longer side chains interact with residues from Phe83 to Phe87. An extra side chain, like warfarin’s alkyl ketone, may not be essential. This proposed structure-activity relationship can serve as a useful guide for designing improved and novel vitamin K antagonists in the future.
format text
author Mortel, Ser Loisse R.
author_facet Mortel, Ser Loisse R.
author_sort Mortel, Ser Loisse R.
title Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
title_short Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
title_full Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
title_fullStr Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
title_full_unstemmed Identification and mechanistic studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors using in silico drug discovery techniques
title_sort identification and mechanistic studies of potential novel vitamin k epoxide reductase (vkor) inhibitors using in silico drug discovery techniques
publisher Animo Repository
publishDate 2023
url https://animorepository.dlsu.edu.ph/etdm_chem/14
https://animorepository.dlsu.edu.ph/context/etdm_chem/article/1013/viewcontent/2023_Mortel_Identification_and_mechanistic_studies_of_potential_novel_vitamin_Full_text.pdf
_version_ 1778174153195520000